Knight Therapeutics Inc(GUD-T)TSX
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr09/2024 | Next Qtr12/2024 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | 0.02 | 0.04 | -0.03 | 0.06 |
| Number of Estimates | 2 | 2 | 2 | 1 |
| High Estimate | 0.06 | 0.07 | 0.06 | 0.06 |
| Low Estimate | -0.02 | 0.00 | -0.11 | 0.06 |
| Prior Year | 0.09 | -0.03 | 0.35 | -0.03 |
| Growth Rate Est. (year over year) | -77.78% | +233.33% | -108.57% | +300.00% |
Earnings History - Surprises*
| Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | Qtr Ending09/2023 | |
|---|---|---|---|---|
| Reported | $-0.02 | $-0.04 | $-0.03 | $0.09 |
| Estimate | $0.03 | $0.02 | $0.02 | $0.03 |
| Difference | -0.05 | -0.06 | -0.05 | +0.06 |
| Surprise | -166.67% | -300.00% | -250.00% | +200.00% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.00
3 Mths Ago4
4.50
2 Mths Ago4
4.50
1 Mth Ago4
4.50
Current4
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 4 | 4 | 4 | 4 |
1 2 | 2 2 | 2 2 | 2 2 | |
| Holds | 1 | 0 | 0 | 0 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell